Dr. Rodney Landreneau

Get to Know Dr. Rodney Landreneau

Highly acclaimed thoracic surgeon Dr. Rodney Landreneau is part of the Pleural & Peritoneal Surface Malignancy Program at Tampa General Hospital Cancer Institute. This unique program provides patients a highly coordinated multidisciplinary care opportunity.

Landreneau has more than 30 years of experience treating patients with esophageal diseases, lung cancer and pleural mesothelioma. Before joining the team at Tampa General Hospital, he was part of The Lung Center at Penn Highlands and served in leadership roles at the University of Pittsburgh Medical Center, Allegheny Health Network and The Gayle and Tom Benson Cancer Center at Ochsner Medical Center in New Orleans.

As a mesothelioma specialist, he built a well-deserved reputation as a medical pioneer, refining the surgical management of pleural mesothelioma. This includes a personalized, multidisciplinary approach to mesothelioma treatment.

Landreneau has experience in both aggressive and minimally invasive thoracic surgery. He handles cases that include esophageal achalasia, esophageal diverticulum, myasthenia gravis and interstitial lung disease.

His clinical interests also include lung cancer molecular biology and brachytherapy management. At Tampa General Hospital, Landreneau works closely with thoracic surgical oncologic surgeons, Dr. K. Eric Sommers, director of thoracic oncology at TGH Cancer institute, and Dr. Jonathan Daniel. TGH Cancer Institute is active in research and is collaborating with the University of Pittsburgh and Baylor College of Medicine in Houston.

Specialties of Dr. Rodney Landreneau

Dr. Rodney Landreneau’s Experience and Medical Education

Awards and Other Recognitions

Medicine Runs in Dr. Landreneau’s Family

His late father was a prominent surgeon in Louisiana, where Landreneau grew up. His two brothers (now deceased) also became surgeons and practiced in the state. His sister is a registered nurse still working there.

“Going to Ochsner was the right move for me at the time,” he said. “From a clinical standpoint, and from a family standpoint. It was the right thing to do.”

Landreneau performed surgical debulking coupled with hyperthermic chemotherapy for mesothelioma in 2013, the first in Louisiana history. It was a procedure he had mastered during his earlier days at the University of Pittsburgh Medical Center.

“There had been a large, underserved population in Louisiana for too long,” he shared. “It was a way to help a lot of people from my home area, particularly those with mesothelioma.”

Publications of Dr. Rodney Landreneau